ENXTPA:ERFLife Sciences
Eurofins Scientific (ENXTPA:ERF) Stock Margins Improve As Turnaround Narrative Gains Support
Eurofins Scientific (ENXTPA:ERF) has just posted H1 2026 results with revenue of €3.7b and basic EPS of €1.55, setting the tone for a set of numbers that investors can now weigh against both recent momentum and longer term trends. The company has seen revenue move from €3.6b and basic EPS of €1.20 in H1 2025 to €3.7b and €1.55 in H1 2026. Trailing twelve month figures now stand at €7.4b of revenue and basic EPS of €2.66, framing a clear earnings season snapshot for holders tracking the story...